Niagen Bioscience (NAGE) Net Margin (2010 - 2026)
Niagen Bioscience (NAGE) reported Net Margin of 20.07% for Q1 2026, up 346.0% year-over-year from 4.5% in Q1 2025, and up 64.39% quarter-over-quarter from 12.21% in Q4 2025.
Niagen Bioscience (NAGE) Net Margin (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 16 years of Net Margin data on file, last reported at 20.07% in Q1 2026.
- Net Margin for Q1 2026 came in at 20.07%, up 346.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.29% (up 122.0% YoY), and the FY2025 annual result was 13.43%, up 485.0% from the prior year.
- Net Margin rose to 20.07% in Q1 2026 per NAGE's latest filing, from 12.21% in the prior quarter.
- Over five years, Net Margin peaked at 24.65% in Q4 2024 and troughed at 44.85% in Q1 2022.
- A 5-year average of 1.66% and a median of 0.07% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2023 and 2025: Net Margin soared 3612 bps in 2023, then sank 1244 bps in 2025.
- A 5-year view of Net Margin shows it stood at 6.88% in 2022, then jumped by 108 bps to 0.54% in 2023, then surged by 4483 bps to 24.65% in 2024, then slumped by 50 bps to 12.21% in 2025, then soared by 64 bps to 20.07% in 2026.
- Business Quant data shows NAGE's Net Margin at 20.07% in Q1 2026, 12.21% in Q4 2025, and 13.47% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.82% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 20.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.07% |
| Dec 31, 2025 | 12.21% |
| Sep 30, 2025 | 13.47% |
| Jun 30, 2025 | 11.60% |
| Mar 31, 2025 | 16.61% |
| Dec 31, 2024 | 24.65% |
| Sep 30, 2024 | 7.34% |
| Jun 30, 2024 | -0.07% |
| Mar 31, 2024 | -2.22% |
| Dec 31, 2023 | 0.54% |
| Sep 30, 2023 | -4.92% |
| Jun 30, 2023 | -10.78% |
| Mar 31, 2023 | -8.72% |
| Dec 31, 2022 | -6.88% |
| Sep 30, 2022 | -17.99% |
| Jun 30, 2022 | -38.23% |
| Mar 31, 2022 | -44.85% |
| Dec 31, 2021 | -29.98% |
| Sep 30, 2021 | -51.17% |
| Jun 30, 2021 | -31.45% |